Furthermore, high Rab1A expression correlates with poor prognosis at all three TNM stages (Figure 7D) in cohort I. Thus, Rab1A level can provide predictive value for the outcome of HCC patients. Here, RAB1A is linked to hepatocellular carcinoma.